Role of mycobacterial efflux transporters in drug resistance:: an unresolved question

被引:220
作者
De Rossi, E
Aínsa, JA
Riccardi, G
机构
[1] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy
[2] Univ Zaragoza, Fac Med, Dept Microbiol Med Prevent & Salud Publ, Zaragoza, Spain
关键词
mycobacteria; drug efflux; intrinsic antibiotic resistance;
D O I
10.1111/j.1574-6976.2005.00000.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Two mechanisms are thought to be involved in the natural drug resistance of mycobacteria: the mycobacterial cell wall permeability barrier and active multidrug efflux pumps. Genes encoding drug efflux transporters have been isolated from several mycobacterial species. These proteins transport tetracycline, fluoroquinolones, aminoglycosides and other compounds. Recent reports have suggested that efflux pumps may also be involved in transporting isoniazid, one of the main drugs used to treat tuberculosis. This review highlights recent advances in our understanding of efflux-mediated drug resistance in mycobacteria, including the distribution of efflux systems in these organisms, their substrate profiles and their contribution to drug resistance. The balance between the drug transport into the cell and drug efflux is not yet clearly understood, and further studies are required in mycobacteria.
引用
收藏
页码:36 / 52
页数:17
相关论文
共 141 条
[51]   PERMEABILITY BARRIER TO RIFAMPIN IN MYCOBACTERIA [J].
HUI, J ;
GORDON, N ;
KAJIOKA, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (05) :773-779
[52]   The drug/metabolite transporter superfamily [J].
Jack, DL ;
Yang, NM ;
Saier, MH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (13) :3620-3639
[53]   High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA [J].
Janoir, C ;
Zeller, V ;
Kitzis, MD ;
Moreau, NJ ;
Gutmann, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2760-2764
[54]   Structure and association of ATP-binding cassette transporter nucleotide-binding domains [J].
Kerr, ID .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1561 (01) :47-64
[55]   The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies [J].
Kuwano, M ;
Uchiumi, T ;
Hayakawa, H ;
Ono, M ;
Wada, M ;
Izumi, H ;
Kohno, K .
CANCER SCIENCE, 2003, 94 (01) :9-14
[56]   Active efflux, a common mechanism for biocide and antibiotic resistance [J].
Levy, SB .
JOURNAL OF APPLIED MICROBIOLOGY, 2002, 92 :65S-71S
[57]   ACTIVE EFFLUX MECHANISMS FOR ANTIMICROBIAL RESISTANCE [J].
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :695-703
[58]   PLASMID-DETERMINED TETRACYCLINE RESISTANCE INVOLVES NEW TRANSPORT-SYSTEMS FOR TETRACYCLINE [J].
LEVY, SB ;
MCMURRY, L .
NATURE, 1978, 276 (5683) :90-92
[59]   Efflux-mediated drug resistance in bacteria [J].
Li, XZ ;
Nikaido, H .
DRUGS, 2004, 64 (02) :159-204
[60]   Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis [J].
Li, XZ ;
Zhang, L ;
Nikaido, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2415-2423